Dimension Therapeutics, Inc. Revenue
Dimension Therapeutics, Inc. reported Revenue of $4.48 million for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-06.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2017-11-06
- Dimension Therapeutics, Inc. revenues for the quarter ending 2017-09-30 was $4.48M, a 62.20% increase year-over-year.
- Dimension Therapeutics, Inc. revenues for the quarter ending 2017-06-30 was $4.37M, a 84.27% increase year-over-year.
- Dimension Therapeutics, Inc. revenues for the quarter ending 2017-03-31 was $3.62M, a 64.01% increase year-over-year.
- Dimension Therapeutics, Inc. revenues for the quarter ending 2016-12-31 was $4.13M, a 75.68% increase year-over-year.
- Dimension Therapeutics, Inc. revenues for fiscal 2016 was $11.47M, a 48.01% increase from fiscal 2015.
- Dimension Therapeutics, Inc. revenues for fiscal 2015 was $7.75M, a 181.82% increase from fiscal 2014.
- Dimension Therapeutics, Inc. revenues for fiscal 2014 was $2.75M.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2017-09-30 | $4.48M 10-Q · filed 2017-11-06 | $8.85M derived: sum of 2 quarters · filed 2017-11-06 | $12.47M 10-Q · filed 2017-11-06 | $16.60M derived: sum of 4 quarters · filed 2017-11-06 |
| 2017-06-30 | $4.37M 10-Q · filed 2017-08-08 | $7.99M 10-Q · filed 2017-08-08 | $12.12M derived: sum of 3 quarters · filed 2017-08-08 | $14.88M derived: sum of 4 quarters · filed 2017-11-06 |
| 2017-03-31 | $3.62M 10-Q · filed 2017-05-10 | $7.75M derived: sum of 2 quarters · filed 2017-05-10 | $10.51M derived: sum of 3 quarters · filed 2017-11-06 | $12.88M derived: sum of 4 quarters · filed 2017-11-06 |
| 2016-12-31 | $4.13M 10-K · filed 2017-03-09 | $6.89M derived: sum of 2 quarters · filed 2017-11-06 | $9.27M derived: sum of 3 quarters · filed 2017-11-06 | $11.47M 10-K · filed 2017-03-09 |
| 2016-09-30 | $2.76M 10-Q · filed 2017-11-06 | $5.13M derived: sum of 2 quarters · filed 2017-11-06 | $7.34M 10-Q · filed 2017-11-06 | $9.69M derived: sum of 4 quarters · filed 2017-11-06 |
| 2016-06-30 | $2.37M 10-Q · filed 2017-08-08 | $4.58M 10-Q · filed 2017-08-08 | $6.93M derived: sum of 3 quarters · filed 2017-08-08 | $8.99M derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-03-31 | $2.21M 10-Q · filed 2017-05-10 | $4.56M derived: sum of 2 quarters · filed 2017-05-10 | $6.62M derived: sum of 3 quarters · filed 2017-05-10 | $8.36M derived: sum of 4 quarters · filed 2017-05-10 |
| 2015-12-31 | $2.35M 10-K · filed 2017-03-09 | $4.41M derived: sum of 2 quarters · filed 2017-03-09 | $6.16M derived: sum of 3 quarters · filed 2017-03-09 | $7.75M 10-K · filed 2017-03-09 |
| 2015-09-30 | $2.06M 10-K · filed 2017-03-09 | $3.80M derived: sum of 2 quarters · filed 2017-03-09 | $5.40M 10-Q · filed 2016-11-10 | $6.80M derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-06-30 | $1.74M 10-K · filed 2017-03-09 | $3.34M 10-Q · filed 2016-08-11 | $4.74M derived: sum of 3 quarters · filed 2017-03-09 | $5.93M derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-03-31 | $1.59M 10-K · filed 2017-03-09 | $3.00M derived: sum of 2 quarters · filed 2017-03-09 | $4.18M derived: sum of 3 quarters · filed 2017-03-09 | $4.34M derived: sum of 4 quarters · filed 2017-03-09 |
| 2014-12-31 | $1.41M 10-K · filed 2016-03-24 | $2.59M derived: sum of 2 quarters · filed 2016-03-24 | $2.75M derived: sum of 3 quarters · filed 2016-03-24 | $2.75M 10-K · filed 2017-03-09 |
| 2014-09-30 | $1.18M 10-K · filed 2016-03-24 | $1.34M derived: sum of 2 quarters · filed 2016-03-24 | $1.34M 10-Q · filed 2015-12-04 | |
| 2014-06-30 | $159.00K 10-K · filed 2016-03-24 |